export const Splash_p3_7 = () => {
    return (
        
            <ol><li>Data on File – IQVIA Monthly &amp; Weekly TRx Data in SMART, U.S. Edition – Weekly and Monthly NPA Data
    (Assessed as of May 2020). Prepared May 2020
</li>
<li>
SOLOSEC [prescribing information]. Baltimore, MD: Lupin Pharmaceuticals, Inc.; 2017
</li>
            </ol>
        
    )
}
export const Acog = () => {
    return (
        
            <ol>
<li>
     American College of Obstetricians and Gynecologists. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetricians-Gynecologists, Number 215. <i>Obstet Gynecol</i> 2020:135(1):e1-e17.
</li>
            </ol>
        
    )
}
export const Acog2 = () => {
    return (
        
        <ol>
            <li>
                American College of Obstetricians and Gynecologists. ACOG Practice Bulletin: Clinical Management
                Guidelines for Obstetricians- Gynecologists, Number 215. <i>Obstet Gynecol</i> 2020:135(1):e1-e17.
            </li>
            <li>
                Data on file. Experience Program: Post Treatment Patient Survey data (May 2019-Sep 2019). Prepared
                September 2019. (LPSO- 23506). Lupin Pharmaceuticals, Inc.

            </li>
            <li>
                SOLOSEC [prescribing information]. Baltimore, MD: Lupin Pharmaceuticals, Inc.; 2017.
            </li>
            <li>
                Data on File, Physician Research. Advantage Healthcare, Inc. Prepared December 23, 2014.

            </li>
            <li>
                Hillier SL, Nyirjesy P, Waldbaum AS, et al. Secnidazole treatment of bacterial vaginosis: a randomized controlled trial. <i>Obstet Gynecol</i>. 2017;130(2):379-386.
            </li>
            <li>
                Schwebke JR, Morgan FG Jr, Koltun W, Nyirjesy P. A phase-3, double-blind, placebo-controlled study of the effectiveness andsafety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis [published correction appears in <i>Am J Obstet Gynecol</i>. 2018;219(1):110]. <i>Am J Obstet Gynecol</i>. 2017;217(6):678.e1-678.e9.
            </li>
        </ol>

        
    )
}
export const Studies = () => {
    return (
        
            <ol>
                <li>
                    SOLOSEC [prescribing information].Baltimore, MD: Lupin Pharmaceuticals, Inc.; 2017.
                </li>
                <li>
                    Hillier SL, Nyirjesy P, Waldbaum AS, et al.Secnidazole treatment of bacterial vaginosis: a
                    randomized controlled trial.<i>Obstet Gynecol</i>. 2017; 130(2): 379 - 386.
                </li>
                <li>
                    Schwebke JR, Morgan FG Jr, Koltun W, Nyirjesy P.A phase - 3, double - blind, placebo - controlled
                    study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of
                    women with bacterial vaginosis[published correction appears in <i>Am J Obstet Gynecol</i>. 2018;
                    219(1): 110].<i>Am J Obstet Gynecol</i>. 2017; 217(6): 678.e1 - 678.e9.doi: 10.1016 /
                    j.ajog.2017.08.017.
                </li>
            </ol>

        
    )
}
export const Pg19 = () => {
    return (
        <ol>
            <li>
                SOLOSEC [prescribing information]. Baltimore, MD: Lupin Pharmaceuticals, Inc.; 2017.
            </li>
            <li>
                Hillier SL, Nyirjesy P, Waldbaum AS, et al. Secnidazole treatment of bacterial vaginosis: a randomized
                controlled trial. <i>Obstet Gynecol</i>. 2017;130(2):379-386.
            </li>
            <li>
                Schwebke JR, Morgan FG Jr, Koltun W, Nyirjesy P. A phase-3, double-blind, placebo-controlled study of
                the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with
                bacterial vaginosis [published correction appears in <i>Am J Obstet Gynecol</i>. 2018;219(1):110]. <i>Am
                J Obstet Gynecol</i>. 2017;217(6):678.e1-678.e9. doi: 10.1016/j.ajog.2017.08.017.
            </li>
        </ol>
    )
}

export const Pg21 = () => {
    return (
        <ol>
           <li>
               Bohbot JM, Vicaut E, Fagnen D, Brauman M. Treatment of bacterial vaginosis: a multi-center, double-dummy, randomized phase III study comparing secnidazole and metronidazole. <i>Infect Dis Obstet Gynecol</i>. 2010;2010:1-6.
            </li>
        </ol>
    )
}

export const Pg23 = () => {
    return (
        <ol>
            <li>
                SOLOSEC [prescribing information]. Baltimore, MD: Lupin Pharmaceuticals, Inc.; 2017.
            </li>

            <li>
                Samir, Z. Overview: How is Alcohol Metabolized by the Body? National Institute on Alcohol Abuse and Alcoholism. Accessed 20 Feb 2019.
                https://pubs.niaaa.nih.gov/publications/arh294/245-255.htm.
            </li>

            <li>
                Noureldin M, Krause J, Jin L, Ng V, Tran M. Drug Alcohol Interactions: A Review of 3 Therapeutic Cases. <i>U.S. Pharmacist</i>. 2017; 17 Nov.
                https://www.uspharmacist.com/article/drug-alcohol-interactions-a-review-of-three-therapeutic-classes. Accessed 20 Feb 2019.
            </li>
             
            <li>
                Flagyl Extended Release [prescribing information]. Chicago, IL: G.D. Searle LLC; 2017.
            </li>

            <li>
                Tinidazole Tablets [prescribing information]. Buffalo Grove, IL: G.D. PACK Pharmaceuticals, LLC; 2013.
            </li>

            <li>
                Metrogel [prescribing information]. Sellersville, PA: Teva Pharmaceuticals USA; 2005.
            </li>

            <li>
                Nuvessa [prescribing information]. Madrid, Spain: Chemo Research SL; 2017.
            </li>

            <li>
                Pentikis HS, Adetoro N. <i>In vitro</i> metabolic profile of secnidazole, a 5-nitroimidazole antibiotic for the treatment of bacterial vaginosis.
                <i>Manuscr Prep</i>. 2017.
            </li>

            <li>
                Gillis JC, Wiseman LR. Secnidazole. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the
                management of protozoal infections and bacterial vaginosis. <i>Drugs</i>. 1996;51(4):621-638. http://www.ncbi.nlm.nih.gov/pubmed/8706597.
            </li>

            <li>
                Lamp KC, Freeman CD, Klutman NE, Lacy MK. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.
                <i>Clin Pharmacokinet</i>. 1999;36(5):353-373. doi:10.2165/00003088-199936050-00004.
            </li>
        </ol>
    )
}

export const Pg25_26 = () => {
    return (
        <ol>
            <li>
                SOLOSEC [prescribing information]. Baltimore, MD: Lupin Pharmaceuticals, Inc.; 2017.
            </li>
            <li>
                Data on File, Physician Research. Advantage Healthcare, Inc. Prepared December 23, 2014.
            </li>
        </ol>
    )
}

export const Pg28 = () => {
    return (
        <ol>
           <li>
SOLOSEC [prescribing information]. Baltimore, MD: Lupin Pharmaceuticals, Inc.; 2017. 
</li>
        </ol>
    )
}

export const Pg30 = () => {
    return (
        <ol>
            <li>
                Data on file. Experience Program: Post Treatment Patient Survey data (May 2019-Sep 2019). Prepared
                September 2019. (LPSO-23506). Lupin Pharmaceuticals, Inc.
            </li>
            <li>
                SOLOSEC [prescribing information]. Baltimore, MD: Lupin Pharmaceuticals, Inc.; 2017.
            </li>
        </ol>
    )
}

export const Pg32 = () => {
    return (
        <ol>
           <li>
SOLOSEC [prescribing information]. Baltimore, MD: Lupin Pharmaceuticals, Inc.; 2017.
</li>
           <li>
Flagyl Extended Release [prescribing information]. Chicago, IL: G.D. Searle LLC; 2018.
</li>
           <li>
Tinidazole Tablets [prescribing information]. Buffalo Grove, IL: G.D. PACK Pharmaceuticals, LLC; 2013.
</li>
           <li>
 Metrogel [prescribing information]. Sellersville, PA: Teva Pharmaceuticals USA; 2005.
</li>
           <li>
Nuvessa [prescribing information]. Madrid, Spain: Chemo Research SL; 2017.
</li>
           <li>
 Clindesse [prescribing information]. Allegan, MI: Pharmacia &amp; Upjohn Company, LLC; 2014.
</li>
        </ol>
    )
}

export const Pg34 = () => {
    return (
        <ol>
           <li>
SOLOSEC [prescribing information]. Baltimore, MD: Lupin Pharmaceuticals, Inc.; 2017.
</li>
            <li>
                Nyirjesy P, Schwebke JR. Secnidazole: next-generation antimicrobial agent for bacterial vaginosis
                treatment. <i>Future Microbiol</i>. 2018;13:507-524. doi:10.2217/fmb-2017-0270.
            </li>
            <li>
                Metronidazole Oral Capsules 500 mg [prescribing information]. Chicago, IL: G.D. Searle LLC; 2018.
            </li>
        </ol>
    )
}

export const Pg36 = () => {
    return (
        <ol>
            <li>
                Schwebke JR, Morgan FG Jr, Koltun W, Nyirjesy P. A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis [published correction appears in <i>Am J Obstet Gynecol</i>. 2018;219(1):110]. <i>Am J Obstet Gynecol</i>. 2017;217(6):678.e1-678.e9. doi: 10.1016/j.ajog.2017.08.017.          </li>
            <li>
                SOLOSEC [prescribing information]. Baltimore, MD: Lupin Pharmaceuticals, Inc.; 2017.
            </li>
        </ol>
    )
}


export const Pg38 = () => {
    return (
        <ol>
           <li>
               Chavoustie SE, Eder SE, Koltun WD, et al. Experts explore the state of bacterial vaginosis and the unmet needs facing women and providers. <i>Int J Gynaecol Obstet</i>. 2017;137(2):107-109.
</li>
           <li>
               Bartley JB, Ferris DG, Allmond LM, Dickman ED, Dias JK, Lambert J. Personal digital assistants used to document compliance of bacterial vaginosis treatment. <i>Sex Transm Dis</i>. 2004;31(8):488-491.
</li>
           <li>
Schwebke JR, Morgan FG Jr, Koltun W, Nyirjesy P. A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis [published correction appears in <i>Am J Obstet Gynecol</i>. 2018;219(1):110]. <i>Am J Obstet Gynecol</i>. 2017;217(6):678.e1-678.e9. doi: 10.1016/j.ajog.2017.08.017.
</li>
        </ol>
    )
}

export const Pg40 = () => {
    return (
        <ol>
           <li>
Data on file. Bacterial Vaginosis Physician Survey. Symbiomix Therapeutics, LLC, a Lupin Company, and the American Sexual Health Association (ASHA). Prepared March 2018.
</li>
        </ol>
    )
}
export const Pg65 = () => {
    return (
        <ol>
            <li>
                1. Koumans EH, Sternberg M, Bruce C, et al. The prevalence of bacterial vaginosis in the United States,
                2001-2004; associations with symptoms, sexual behaviors, and reproductive health. <i>Sex Transm Dis</i>.
                2007;34(11):864-869.
            </li>
            <li>
                2. Allsworth JE, Lewis VA, Peipert JF. Viral sexually transmitted infections and bacterial vaginosis:
                2001-2004 National Health and Nutrition Examination Survey data. <i>Sex Transm Dis</i>.
                2008;35(9):791-79.
            </li>
        </ol>
    )
}

export const Pg66 = () => {
    return (
        <ol>
            <li>
                Koumans EH, Sternberg M, Bruce C, et al. The prevalence of bacterial vaginosis in the United States,
                2001-2004; associations with symptoms, sexual behaviors, and reproductive health. <i>Sex Transm Dis</i>.
                2007;34(11):864-869.
            </li>
            <li>
                Brookheart RT, Lewis WG, Peipert JF, Lewis AL, Allsworth JE. Association between obesity and bacterial
                vaginosis as assessed by Nugent Score. <i>Am J Obstet Gynecol</i>. 2019;220(5):476.e1-476.e11.
            </li>
            <li>
                Workowski KA, Bolan GA; CDC. Sexually Transmitted Diseases Treatment Guidelines, 2015 [published
                correction appears in <i>MMWR Recomm Rep</i>. 2015;64(33):924]. <i>MMWR Recomm Rep</i>.
                2015;64(RR-03):1-13.
            </li>
        </ol>
    )
}

export const Pg68 = () => {
    return (
        <ol>
           <li>
               Workowski KA, Bolan GA; CDC. Sexually Transmitted Diseases Treatment Guidelines, 2015 [published correction appears in <i>MMWR Recomm Rep</i>. 2015;64(33):924]. <i>MMWR Recomm Rep</i>. 2015;64(RR-03):1-137.
           </li>
        </ol>
    )
}

export const Pg71 = () => {
    return (
        <ol>
            <li>
                SOLOSEC [prescribing information]. Baltimore, MD: Lupin Pharmaceuticals, Inc.; 2017.
            </li>
        </ol>
    )
}
export const Nope = () => {
    return (
        <h1>

        </h1>
    )
}